|Awarded On||February 16, 2022|
|Title||Liver Cancer Prevention Among Those with Experiences of Homelessness: An Expansion to Low-Income Housing in South Texas|
|Award Mechanism||Expansion of Cancer Prevention Services to Rural and Medically Underserved Populations|
|Institution/Organization||The University of Texas Health Science Center at Houston|
|Principal Investigator/Program Director||Vanessa R Schick|
|Cancer Sites||Gallbladder, Liver and Intrahepatic Bile Duct|
*Pending contract negotiation
Need: Mortality due to liver cancer is increasing at a rate that is faster than any other cancer with an incidence rate that is the second fastest growing of all cancers. Incidence rates in South Texas range from 9.9 to 28.9 and are continuing to rise in some high need counties (e.g., Bexar, Frio). Among individuals with liver cancer, hepatitis is a contributing factor in 65-78% of cases, making prevention and treatment of Hepatitis B (HBV) and Hepatitis C (HCV) one of the most effective ways to reduce liver cancer. Prevalence of HCV among persons experiencing homelessness (PEH) range from 22-69% and 23-40% for HBV. Although vaccination for HBV and treatment of HCV could reduce the prevalenc...